Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
β No difference in overall survival with versus without bolus, less toxicity without
Latest in Oncology/Hematology
This difference is mostly explained by their smaller stature, researchers say
News, features, and commentary about cancer-related issues
Combination for leiomyosarcoma improved OS by 9 months versus doxorubicin alone
Combination for leiomyosarcoma improved OS by 9 months versus doxorubicin alone
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Patient achieves remission with biologic agent currently used for myeloma
Having a medical condition was tied to increased risk of suicide in a dose-response-like manner
Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5%
Health news and commentary gathered by ΔΎΉΟΦ±²₯ staff
Responses to pirtobrutinib observed in patients with previously treated disease
Recommendations for short-interval follow-up or biopsy likely a factor
News, features, and commentary about cancer-related issues
Meta-analysis shows ICIs also improved pCR rates in HR-positive/HER2-negative disease
Agency has delayed the target date twice
Results from some pulmonary function tests even showed improvement 3 years post-transplant
A deep dive with Rob Newton, a pioneer in the field of exercise oncology
But editorialists call USPSTF-recommended screening option "outdated"
Better survival in one registry study, detriment with class I HLA mismatch in another
